PDE5 Inhibitors Enhance the Lethality of Standard of Care Chemotherapy in Pediatric CNS Tumor Cells

Cancer Biology and Therapy - United States
doi 10.4161/cbt.28553
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

PDE5 Inhibitors Enhance the Lethality of [Pemetrexed + Sorafenib]

Oncotarget
Oncology
2017English

Engineered Drug-Resistant Immunocompetent Cells Enhance Tumor Cell Killing During a Chemotherapy Challenge

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2010English

HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget
Oncology
2017English

Pharmacological Modulation of Cytotoxicity and Cellular Uptake of Anti-Cancer Drugs by PDE5 Inhibitors in Lung Cancer Cells

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2013English

Pediatric CNS Tumors

Pediatric Oncology
2004English

Immune Cells Enhance Selectivity of Nanosecond-Pulsed Plasma Against Tumor Cells

Plasma Medicine
PhysicsAstronomyBiomedical Engineering
2017English

Psychosocial Follow-Up in Survivorship as a Standard of Care in Pediatric Oncology

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2015English

Is a Shift in the Standard of Care Chemotherapy for Patients With Esophageal Cancer Premature?

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Non CNS Pediatric Malignancies in Mosul

Annals of the College of Medicine, Mosul
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy